Search Results - "tuberculosis"

  1. 41
  2. 42

    Nutritional status evaluation and nutrient intake in adult patients with pulmonary tuberculosis and their contacts by Campos Góngora, Eduardo, López Martínez, Julieta Melissa, Huerta Oros, Joselina, Arredondo Mendoza, Gerardo Ismael, Jiménez Salas, Zacarías

    Published 2019
    “…Introduction: Malnutrition is a common status in patients with tuberculosis (TB). Because TB is disseminated through the sputum of infected persons, individuals who maintain relations with a TB patient are at high risk of infection; this risk is greater when contacts present an inadequate nutritional status. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47

    Efecto de ESAT-6 de mycobacterium tuberculosis en la polarización de macrófagos. by Rodríguez Mier, David

    Published 2016
    “…Propósito y Método del Estudio: El agente causal más común de la tuberculosis es Mycobacterium tuberculosis. El macrófago es la célula blanco de este agente, está célula es parte de las respuesta inmunológica innata. …”
    Get full text
    Tesis
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52

    COMPORTAMIENTO EPIDEMIOLÓGICO DE LA TUBERCULOSIS EN QUERÉTARO, MÉXICO: EVALUACIÓN DE 5 AÑOS by Márquez García, Guadalupe, Escartín Chávez, Minerva, Milián Suazo, Feliciano, Pérez Guerrero, Laura

    Published 2008
    “…El objetivo del presente estudio fue conocer el comportamiento epidemiológico de la tuberculosis (TB) en el estado de Querétaro, México. …”
    Get full text
    Article
  13. 53

    Measuring of Mycobacterium tuberculosis growth: a correlation of the optical measurements with colony forming units by Peñuelas Urquides, Katia, Villarreal Treviño, Licet, Silva Ramírez, Beatriz, Rivadeneyra Espinoza, Liliana, Said Fernández, Salvador, León, Mario Bermúdez de

    Published 2013
    “…The quantification of colony forming units (cfu), turbidity, and optical density at 600 nm (OD600) measurements were used to evaluate Mycobacterium tuberculosis growth. Turbidity and OD600 measurements displayed similar growth curves, while cfu quantification showed a continuous growth curve. …”
    Get full text
    Article
  14. 54

    Measuring of Mycobacterium tuberculosis growth: a correlation of the optical measurements with colony forming units by Peñuelas Urquides, Katia, Villarreal Treviño, Licet, Silva Ramírez, Beatriz, Rivadeneyra Espinoza, Liliana, Said Fernández, Salvador, León, Mario Bermúdez de

    Published 2013
    “…The quantification of colony forming units (cfu), turbidity, and optical density at 600 nm (OD600) measurements were used to evaluate Mycobacterium tuberculosis growth. Turbidity and OD600 measurements displayed similar growth curves, while cfu quantification showed a continuous growth curve. …”
    Get full text
    Article
  15. 55

    Diterpenes Synthesized from the Natural Serrulatane Leubethanol and Their in Vitro Activities against Mycobacterium tuberculosis by Escarcena, Ricardo, Pérez Meseguer, Jonathan, Del Olmo, Esther, Alanís Garza, Blanca Alicia, Garza González, Elvira, Salazar Aranda, Ricardo, Waksman de Torres, Noemí

    Published 2015
    “…Seventeen new derivatives of the natural diterpene leubethanol, including some potential pro-drugs, with changes in the functionality of the aliphatic chain or modifications of aromatic ring and the phenolic group, were synthesized and tested in vitro by the MABA technique for their activity against the H37Rv strain of Mycobacterium tuberculosis. Some compounds showed antimycobacterial selectivity indices higher than leubethanol.…”
    Get full text
    Article
  16. 56

    Potential mechanism of action of meso-dihydroguaiaretic acid on mycobacterium tuberculosis H37Rv by Clemente Soto, Aldo Francisco, Balderas Rentería, Isaías, Rivera, Gildardo, Segura Cabrera, Aldo, Garza González, Elvira, Camacho Corona, María del Rayo

    Published 2014
    “…The isolation and characterization of the lignan meso-dihydroguaiaretic acid (MDGA) from Larrea tridentata and its activity against Mycobacterial tuberculosis has been demonstrated, but no information regarding its mechanism of action has been documented. …”
    Get full text
    Article
  17. 57
  18. 58
  19. 59

    Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study by Akkerman, Onno, Aleksa, Alena, Alffenaar, Jan Willem, Al-Marzouqi, Nada Hassan, Arias Guillén, Miguel, Belilovski, Evgeny, Bernal, Enrique, Boeree, Martin J., Borisov, Sergey, Bruchfeld, Judith, Cadiñanos Loidi, Julen, Cai, Qingshan, Caminero, Jose A., Cebrian Gallardo, Jose Joaquín, Centis, Rosella, Codecasa, Luigi Ruffo, D’Ambrosio, Lia, Dalcolmo, Margareth Pretti, Danila, Edvardas, Dara, Masoud, Davidavičienė, Edita, Davies Forsman, Lina, De Los Rios Jefe, Jorge, Denholm, Justin, Duarte, Raquel, Elamin, Seifeldin Eltaeb, Ferrarese, Maurizio, Filippov, Alexey, Ganatra, Shashank, Garcia, Ana, García García, José María, Gayoso, Regina, Giraldo Montoya, Angela Maria, Gómez Rosso, Roscio Gómez, Gualano, Gina, Hoefsloot, Wouter, Ilievska Poposka, Biljana, Jonsson, Jerker, Khimova, Elena, Kuksa, Liga, Kunst, Heinke, Laniado Laborín, Rafael, Li, Yang, Magis Escurra, Cecile, Manfrin, Vinicio, Manga, Selene, Marchese, Valentina, Martínez Robles, Elena, Maryandyshev, Andrei, Matteelli, Alberto, Migliori, Giovanni Battista, Mullerpattan, Jai B., Muñoz Torrico, Marcela, Mustafa Hamdan, Hamdan, Nieto Marcos, Magnolia, Noordin, Noorliza Mohamad, Palmero, Domingo Juan, Palmieri, Fabrizio, Payen, Marie Christine, Piubello, Alberto, Pontali, Emanuele, Pontarelli, Agostina, Quirós, Sarai, Rendón, Adrián, Skrahina, Alena, Smite, Agnese, Solovic, Ivan, Sotgiu, Giovanni, Souleymane, Mahamadou Bassirou, Spanevello, Antonio, Stošić, Maja, Tadolini, Marina, Tiberi, Simon, Udwadia, Zarir Farokh, Van den Boom, Martin, Vescovo, Marisa, Viggiani, Pietro, Visca, Dina, Zhurkin, Dmitry, Zignol, Matteo

    Published 2019
    “…AEs were prospectively collected ensuring potential attribution of the AE to a specific drug based on its known safety profile.A total of 309 cases were fully reported from 41 centres in 27 countries (65% males; 268 treated with bedaquiline, 20 with delamanid, and 21 with both drugs) out of an estimated 781 cases the participating countries had committed to report by the first quarter of 2019. Keywords: Tuberculosis, MDR-TB, Adverse events, Monitoring, Delamanid, Bedaquiline…”
    Get full text
    Article
  20. 60

Search Tools: